Milestone Scientific Files 8-K for Disclosure and Exhibits
Ticker: MLSS · Form: 8-K · Filed: Sep 27, 2024 · CIK: 855683
| Field | Detail |
|---|---|
| Company | Milestone Scientific Inc. (MLSS) |
| Form Type | 8-K |
| Filed Date | Sep 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials, 8-k
Related Tickers: MSNI
TL;DR
MSNI filed an 8-K on 9/27 for disclosures and financials.
AI Summary
Milestone Scientific Inc. filed an 8-K on September 27, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details events and financial information as of September 27, 2024. The company is incorporated in Delaware and its principal executive offices are located in Roseland, NJ.
Why It Matters
This 8-K filing provides important updates and financial information for Milestone Scientific Inc., which is crucial for investors to understand the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K for disclosures and exhibits, not indicating any immediate financial distress or significant operational changes.
Key Players & Entities
- MILESTONE SCIENTIFIC INC. (company) — Registrant
- September 27, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Roseland, NJ (location) — Address of principal executive offices
- 001-14053 (identifier) — Commission File Number
FAQ
What is the primary purpose of this 8-K filing for Milestone Scientific Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as of September 27, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 27, 2024.
In which state is Milestone Scientific Inc. incorporated?
Milestone Scientific Inc. is incorporated in Delaware.
What is the address of Milestone Scientific Inc.'s principal executive offices?
The address of Milestone Scientific Inc.'s principal executive offices is 425 Eagle Rock Avenue Suite 403 Roseland, NJ 07068.
What is the Commission File Number for Milestone Scientific Inc.?
The Commission File Number for Milestone Scientific Inc. is 001-14053.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-09-27 10:02:28
Filing Documents
- mlss20240925_8k.htm (8-K) — 26KB
- ex_727738.htm (EX-99.1) — 9KB
- slide01.jpg (GRAPHIC) — 59KB
- slide02.jpg (GRAPHIC) — 91KB
- slide03.jpg (GRAPHIC) — 62KB
- slide04.jpg (GRAPHIC) — 45KB
- slide05.jpg (GRAPHIC) — 43KB
- slide06.jpg (GRAPHIC) — 54KB
- slide07.jpg (GRAPHIC) — 58KB
- slide08.jpg (GRAPHIC) — 61KB
- slide09.jpg (GRAPHIC) — 54KB
- slide10.jpg (GRAPHIC) — 55KB
- slide11.jpg (GRAPHIC) — 53KB
- slide12.jpg (GRAPHIC) — 59KB
- slide13.jpg (GRAPHIC) — 70KB
- slide14.jpg (GRAPHIC) — 35KB
- 0001437749-24-030130.txt ( ) — 1268KB
- mlss-20240927.xsd (EX-101.SCH) — 3KB
- mlss-20240927_def.xml (EX-101.DEF) — 12KB
- mlss-20240927_lab.xml (EX-101.LAB) — 15KB
- mlss-20240927_pre.xml (EX-101.PRE) — 12KB
- mlss20240925_8k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure . On September 27, 2024, the Company published an investor presentation on its website at https://tffpharma.com/investors/. A copy of the investor presentation is attached as Exhibit 99.1 hereto. The information in this Item 7.01, including the investor presentation attached as Exhibit 99.1, is furnished pursuant to Item 7.01 but shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall either be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Method Filing Exhibit 99.1 The Company's investor presentation materials (Furnished) Filed Electronically herewith 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MILESTONE SCIENTIFIC INC. Dated: September 27, 2024 /s/ Arjan Haverhals Arjan Haverhals, Chief Executive Officer 2